Artiva Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Artiva Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Artiva Biotherapeutics Inc
Rating: 1.63808325
Author: Trendlyne DVM scores

about

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the compan...

3.61 0.50 (16.08%)

79.15% Fall from 52W High

128.3K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Neutral

50.7 / 100

1Yr Price target upside is 327%

5 analysts

Artiva Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Artiva Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the compan...

79.15% Fall from 52W High

SWOT Analysis

Artiva Biotherapeutics Inc Live Price Chart